Nomegestrol Acetate/EstradiolIn Oral Contraception

被引：0
|
作者：
Lily P. H. Yang
Greg L. Plosker
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Estradiol; Acne; Ethinylestradiol; Combine Oral Contraceptive; Contraceptive Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Nomegestrol acetate/estradiol is a combined oral contraceptive with approval in many countries. This fixed-dose combination tablet contains nomegestrol acetate, a highly selective progestogen, and estradiol, a natural estrogen. It is the first monophasic combined oral contraceptive to contain estradiol, and is taken in 28-day cycles, consisting of 24 active therapy days with 4 placebo days (i.e. 24/4-day cycles).
引用
收藏
页码：1917 / 1928
页数：11
相关论文
共 50 条
  • [41] Oral combined contraception: Is there any difference between ethinyl-estradiol and estradiol?
    Tremollieres, F.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2012, 40 (02): : 109 - 115
  • [42] Triphasic versus monophasic oral contraceptives for contraception
    Van Vliet, Huib A. A. M.
    Grimes, David A.
    Lopez, Laureen M.
    Schulz, Kenneth F.
    Helmerhorst, Frans M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11):
  • [43] Noncontraceptive health benefits of combined oral contraception
    Baird, DT
    Collins, J
    Crosignani, PG
    Glasier, A
    Jacobs, HS
    La Vecchia, C
    Milsom, I
    Reid, B
    Templeton, A
    Vercellini, P
    Benagiano, G
    Frigerio, GC
    Hoppe, G
    Liberatore, S
    Schmidt-Gollwitzer, K
    Skouby, SO
    Crosignani, PG
    HUMAN REPRODUCTION UPDATE, 2005, 11 (05) : 513 - 525
  • [44] A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception
    Shohel, Mohammad
    Rahman, Mohammad Mahfuzur
    Zaman, Asif
    Uddin, Mir Muhammad Nasir
    Al-Amin, Md Mamun
    Reza, Hasan Mahmud
    BMC WOMENS HEALTH, 2014, 14
  • [45] Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study
    Chabbert-Buffet, Nathalie
    Chassard, Didier
    Ochsenbein, Edith
    Thomas, Jean-Louis
    Christin-Maitre, Sophie
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (02) : 76 - 84
  • [46] Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception
    Jatlaoui, Tara C.
    Riley, Halley
    Curtis, Kathryn M.
    CONTRACEPTION, 2016, 93 (02) : 93 - 112
  • [47] CARDIOVASCULAR RISK-FACTORS AND COMBINED ESTROGEN-PROGESTIN REPLACEMENT THERAPY - A PLACEBO-CONTROLLED STUDY WITH NOMEGESTROL ACETATE AND ESTRADIOL
    CONARD, J
    DENIS, C
    BASDEVANT, A
    GUYENE, TT
    THOMAS, JL
    DEGRELLE, H
    OCHSENBEIN, E
    FERTILITY AND STERILITY, 1995, 64 (05) : 957 - 962
  • [48] Non-contraceptive uses and benefits of combined oral contraception
    Carey, Molly S.
    Allen, Rebecca H.
    OBSTETRICIAN & GYNAECOLOGIST, 2012, 14 (04) : 223 - 228
  • [49] Oral Contraception and the Risk of ThromboembolismWhat Does it Mean to Clinicians and Their Patients?
    James Drife
    Drug Safety, 2002, 25 : 893 - 902
  • [50] Hormonal oral contraception-Which preparation for which patient?
    Roemer, Thomas
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2021, 19 (04): : 259 - 267
12345